September 2022 • PharmaTimes Magazine • 4-5

Contents

Features

Medicine access is at the summit of the global digital agenda

‘Population health’ must start with a holistic approach to well-being

Redefining the power of next-generation sequencing

Five ways that humanised tech can relieve admin burnout across the NHS

Lessons from the COVID-19 response can help us next time

Analysis

Who are they, what do they look like and how can we collaborate?

Can the digital era really bring patient-centricity to pharma?

AI may hold the key to igniting mobile clinical trials

Precision medicine takes off

Unlocking innovative pharma commercialisation opportunities

SmartPeople

21.
Biohazard
How sustainable are biocatalysts in pharma?

26.
Coffee and chat with...
Johnson & Johnson's skiing and MedTech luminary Erin McEachren

28.
Reality check
NakedEye are treating patients as individuals

31.
We can see clearly now
Just-in-time strategies

34.
Your moves
Where you're going and what you're doing there

38.
In the running
Improve your digital marketing with RACE

0
Logo

PharmaTimes

PharmaTimes is the UK’s leading pharmaceutical magazine, tracking the trends and issues that affect the industry here in the UK, in Europe and across the world. We deliver independent, authoritative and trustworthy content through impartial, balanced and informed opinion and analysis.

PharmaTimes print and digital magazine has a distributed circulation of 19,000, reaching right across the industry into every company and every function, bridging the gap between Pharma and the NHS.

editorial@pharmatimes.com
https://pharmatimes.com/
Privacy Policy
Terms of Service

Categories

Explore our inspiring content by topic

PharmaTimes
News
Features
Analysis
SmartPeople

Social Footprints

Follow us on our Social Media Channels

X
linkedin